Pfizer (PFE) EBT Margin Growth (5y) (2014 - 2026)

Pfizer (PFE) EBT Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 9,632.00
Sep 28, 2025 13,954.00
Jun 29, 2025 10,324.00
Mar 30, 2025 10,362.00
Sep 29, 2024 98,214.00
Jun 30, 2024 -3,200.00
Mar 31, 2024 -996.00
Dec 31, 2023 67,950.00
Oct 1, 2023 -23,518.00
Jul 2, 2023 3,140.00
Apr 2, 2023 14,089.00
Oct 2, 2022 1,254.00
Jul 3, 2022 1,168.00
Apr 3, 2022 435.00
Oct 3, 2021 2,034.00
Jul 4, 2021 1,844.00
Apr 4, 2021 1,183.00
Sep 27, 2020 -1,677.00
Jun 28, 2020 82.00
Mar 29, 2020 -18.00